Evidence map›Paper›PMID 32536054›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2020

[Comparison of clinical features between patients with acute-on-chronic liver failure and decompensated liver cirrhosis combined with acute kidney injury].

W W Kang, L P Duan, M M Xu, M Kong, Y Y Cao, F Liu, T Han, Z P Duan, Y Chen, China Network for Severe Liver Diseases(CNSLD)

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Comparison of tenofovir alafenamide and entecavir for hepatitis B virusZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

W W KangDepartment of Nephropathy of Urinary Center Liver Disease, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China.
L P DuanLinpanyuan District, Linyi County Hospital of Traditional Chinese Medicine, Dezhou City, Shandong Province 251500, China.
M M XuDifficult & Complicated Liver Diseases and Artificial Liver Center, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
M KongDifficult & Complicated Liver Diseases and Artificial Liver Center, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
Y Y CaoDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin 300170, China.
F LiuDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin 300170, China.
T HanDepartment of Hepatology, Third Central Hospital of Tianjin, Tianjin 300170, China.
Z P DuanDifficult & Complicated Liver Diseases and Artificial Liver Center, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
Y ChenDifficult & Complicated Liver Diseases and Artificial Liver Center, Beijing You'an Hospital Affiliated to Capital Medical University, Beijing 100069, China; Beijing Municipal Key Laboratory of Liver Failure and Artificial Liver Treatment Research, Beijing 100069, China.
China Network for Severe Liver Diseases(CNSLD)
Beijing YouAn Hospital · CNTianjin Third Central Hospital · CNLinyi City Chinese Medicine Hospital · CN

Funding

"Beijing Municipal Administration of Hospitals Clinical Medicine Development of Special Funding Support" ZYLX201806National Key R&D Program of China 2017YFA0103000National Natural Science Foundation of China 81870429National Science and Technology Major Project 2017ZX10203201-005, 2017ZX10203201-007Young and Middle-aged Talents Incubation Project of You'an Liver Disease and AIDS Fund of Beijing You'an Hospital Affiliated to Capital Medical University BJYAYY-GG2019-03
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Kidney InjuryAcute-On-Chronic Liver FailureLiver CirrhosisCreatinineHumansPrognosisRetrospective StudiesCreatinineAcute-on-chronic liver failureAcute renal injuryDecompensated cirrhosis

Identifiers

PMID32536054
PMCPMC12770663
OpenAlexW3035117444

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.